Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...

Pantoprazole (as sodium) 40mg; per vial; pwd for IV infusion after reconstitution and dilution; contains edetate disodium. Supplied in a single-dose vial as a white to off-white freeze-dried powder ...

Pantoprazole (as sodium) 40mg; per pkt; e-c del-rel granules. Swallow whole. Do not crush or chew granules. Susp: Take 30mins before a meal. Mix contents of packet in 5mL of apple juice or applesauce ...

Pfizer is going after Teva for lost profits and damages. --Courtesy of Pfizer Turns out, Teva Pharmaceutical Industries' ($TEVA) at-risk launch of copycat Protonix ...

NEW YORK — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of ...

NEW YORK (AP) -- Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...

(Reuters) - Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S.

Teva had launched its generic version of Protonix in Dec 2007, well ahead of the patent expiry date of Jan 2011. Teva’s sales of generic Protonix prior to Jan 2011 were about $1.1 billion. While Teva ...

TORONTO, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced that it has notified the U.S. Food and Drug Administration (FDA) that it has ...

(Reuters) – Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S.

Teva Pharmaceutical Industries ($TEVA) knew it was taking a gamble in 2007 when it launched a generic version of Protonix before its patent expiration--just not a $2 ...

Teva Pharmaceutical Industries Ltd. may be on the hook for up to $2.1 billion in damages because it sold generic copies of Pfizer Inc.'s heartburn reliever Protonix before the drug's U.S. patent ...